GSK-3β inhibitor 2
Product Specifications
UNSPSC Description
GSK-3β inhibitor 2 (Compound 3) is a potent, selective and orally active GSK-3β inhibitor with an IC50 of 1.1 nM. GSK-3β inhibitor 2 can cross the blood-brain barrier. GSK-3β inhibitor 2 has the potential for Alzheimer's disease[1].
Target Antigen
GSK-3
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR;Stem Cell/Wnt
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/gsk-3β-inhibitor-2.html
Purity
96.63
Solubility
DMSO : 5 mg/mL (ultrasonic)
Smiles
O=C(C1=C(OC)N=C(C2=CC(NC(C3CC3)=O)=NC=C2)S1)N
Molecular Weight
318.35
References & Citations
[1]Sivaprakasam P, et al. Discovery of new acylaminopyridines as GSK-3 inhibitors by a structure guided in-depth exploration of chemical space around a pyrrolopyridinone core. Bioorg Med Chem Lett. 2015 May 1;25(9):1856-63.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-130795/GSK-3β-inhibitor-2-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-130795/GSK-3β-inhibitor-2-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1702428-31-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7018239-01 0.02 mg
Recombinant Saccharomyces cerevisiae Probable endonuclease LCL3 (LCL3)
Ask
View Details MBS7018239-02 0.1 mg
Recombinant Saccharomyces cerevisiae Probable endonuclease LCL3 (LCL3)
Ask
View Details MBS7018239-03 5x 0.1 mg
Recombinant Saccharomyces cerevisiae Probable endonuclease LCL3 (LCL3)
Ask
View Details